Renalytix (Reg S) (RENX) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Jul 2023 01:43 PM
RNS
Issue of Shares - Replacement
17 Jul 2023 07:00 AM
RNS
Issue of Shares
07 Jul 2023 07:00 AM
RNS
KidneyIntelX evidence presented at ADA
06 Jul 2023 05:38 PM
RNS
Grant of Share Options
03 Jul 2023 07:00 AM
RNS
Directorate Change
30 Jun 2023 07:00 AM
RNS
FDA Approves KidneyIntelX.dkd™
15 Jun 2023 07:00 AM
RNS
Presentation of Scientific Data
09 Jun 2023 07:00 AM
RNS
Financial Results for Q3 of Fiscal Year 2023
08 Jun 2023 03:30 PM
RNS
Result of General Meeting
05 Jun 2023 07:00 AM
RNS
Notice of Q3 Results
25 May 2023 07:00 AM
RNS
EVERSANA® partnership for KidneyIntelX
22 May 2023 07:00 AM
RNS
Expansion of insurance coverage for KidneyIntelX
11 May 2023 07:00 AM
RNS
Notice of GM and Posting of Circular
19 Apr 2023 07:00 AM
RNS
Real-World Evidence Shows KidneyIntelXT Utility
12 Apr 2023 07:00 AM
RNS
Positive Data Release at NKF Conference
30 Mar 2023 07:00 AM
RNS
Half-year Report
27 Mar 2023 12:50 PM
RNS
Business Update - Replacement
27 Mar 2023 07:00 AM
RNS
Business Update
22 Mar 2023 07:00 AM
RNS
Notice of Results
21 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
21 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
21 Mar 2023 07:00 AM
RNS
Update on FDA De Novo Authorization Process
13 Mar 2023 07:00 AM
RNS
Statement re. Silicon Valley Bank
07 Mar 2023 07:00 AM
RNS
Issue of Shares
10 Feb 2023 03:13 PM
RNS
Holding(s) in Company
10 Feb 2023 02:01 PM
RNS
Director/PDMR Shareholding
09 Feb 2023 07:00 AM
RNS
RENX to Participate in the BTIG MedTech Conference
08 Feb 2023 07:00 AM
RNS
Renalytix announces a c.$20.3m private placement
26 Jan 2023 07:00 AM
RNS
Renalytix and Partners Awarded $10 Million Grant
09 Jan 2023 11:05 AM
RNS
Second Price Monitoring Extn
09 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
09 Jan 2023 07:00 AM
RNS
Completes Agreement with Veterans Administration
19 Dec 2022 12:01 PM
RNS
Result of AGM
01 Dec 2022 07:00 AM
RNS
Clinical utility study data: further highlights
30 Nov 2022 07:00 AM
RNS
Results for First Quarter of Fiscal Year 2023
29 Nov 2022 07:00 AM
RNS
Publication of new real world evidence
22 Nov 2022 07:00 AM
RNS
Notice of Q1 FY23 Results
10 Nov 2022 07:00 AM
RNS
Publication of Annual Report 2022 & Notice of AGM
09 Nov 2022 04:35 PM
RNS
Price Monitoring Extension
03 Nov 2022 07:00 AM
RNS
RENX to Present at Stifel Healthcare Conference
31 Oct 2022 04:41 PM
RNS
Second Price Monitoring Extn
31 Oct 2022 04:36 PM
RNS
Price Monitoring Extension
31 Oct 2022 07:00 AM
RNS
Renalytix Reports Full Year Fiscal 2022 Results
26 Oct 2022 09:05 AM
RNS
Second Price Monitoring Extn
26 Oct 2022 09:00 AM
RNS
Price Monitoring Extension
25 Oct 2022 07:00 AM
RNS
KidneyIntelX Medicare Update
24 Oct 2022 07:00 AM
RNS
Notice of Results
17 Oct 2022 07:00 AM
RNS
Presentations accepted at ASN Kidney Week
20 Sep 2022 07:50 AM
RNS
Directorate Change
12 Sep 2022 07:00 AM
RNS
Issue of shares

Renalytix is an artificial intelligence-enabled in vitro diagnostics company which focuses on kidney disease

Renalytics share price launched at 120p in 2018.

UK 100

Latest directors dealings